152726 - Discontinuing osteoporosis pharmacotherapy in postmenopausal women – can they risk taking a break?
- : Online
A four-part newsletter series on osteoporosis therapy in post-menopausal women. This Clinical Brief 4-part series will explore the evidence for the importance of long-term therapy in osteoporosis, and the risks of taking a "drug holiday".Relevance to General Practice
Despite the availability of safe and efficacious PBS-subsidised pharmacotherapy, osteoporosis is significantly under-diagnosed and inadequately managed in Australia. With an ageing population and without improvements in in treatment rates, the incidence of osteoporotic fracture is expected to increase by an estimated 11% over the next 5 years. This 4-part Clinical Brief series explores evidence for the importance of long-term pharmacotherapy in osteoporosis, and the issues that GPs need to be aware of when considering the possibility of a ‘drug holiday’’Learning outcomes